New VA database study is the latest to find a small but significant increased risk for nonarteritic anterior ischemic optic neuropathy. Medscape Medical News
Tag: News
FDA Withdraws Proposal to Prohibit Minors From Tanning Beds
‘Restricting teens’ access to indoor tanning and informing the public about the dangers of indoor tanning are critical to preventing skin cancer,’ AAD President Susan C. Taylor, MD, said. Medscape Medical News
US FDA Declines to Approve Aldeyra’s Eye Disorder Drug, Shares Slump
The U.S. Food and Drug Administration declined to approve Aldeyra Therapeutics’ drug for a type of eye disease, the company said on Tuesday, sending its shares plunging… Reuters Health Information
Change Healthcare Breach Still Affecting Docs, Hospitals
Physicians and hospitals alike are still digging out financially from the impact of the massive Change Healthcare hack in 2024. Medscape Medical News
Genomics and AI Will Up Precision of Glaucoma Care
Polygenic risk scores in development for glaucoma could usher in more personalized estimates of risk. Medscape Medical News
Cosmetic Eyelash Extensions Raise Eye Safety Concerns
Eyelash extensions may contribute to blepharitis, dry eye disease, and corneal injury through meibomian gland dysfunction. Medscape News Australia
Spanish Researchers Develop Low-cost Artificial Cornea From Fish Scales
Researchers at Spain’s University of Granada have developed an artificial cornea made from the scales of several fish species commonly found in markets, which could become… Reuters Health Information
Could Blood Pressure Meds Worsen Glaucoma Damage?
Patients with glaucoma who had low 24-hour systemic blood pressure were more likely to lose retinal nerve fiber layer despite well-controlled intraocular pressure. Medscape Medical News
Pediatric Rheumatologist Explains Updated ACR JIA Guidelines
The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS. Medscape Medical News
Study Links Air Pollution and Failed Glaucoma Surgery
A population study of California Medicare patients found that high air pollution levels correlated with the risk for failure of incisional glaucoma surgery. Medscape Medical News
Glaucoma Coaches Boost Med Adherence, Study Finds
Patients who went through the SEE program in Michigan were more likely to stick to their drug regimen and reported less distress related to their condition. Medscape Medical News
Positive Topline Results for Efgartigimod in Ocular MG
Efgartigimod led to statistically significant improvement in key symptoms of ocular myasthenia gravis compared with placebo in a phase 3 trial. Medscape Medical News
Trabeculectomy Often More Cost-Effective Than Tube Shunts
Analysis of data from a randomized trial finds trabeculectomy typically is the better financial bet than tube shunt surgery as a first option to treat glaucoma. Medscape Medical News
Are Visual Deficits After Stroke Being Missed?
The European Stroke Organization calls for systematic screening within days of stroke to detect visual deficits that affect up to three quarters of survivors. Medscape News Europe
Endophthalmitis a Risk for Years After Tube Shunt Surgery
The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a device-placement surgery for detached retina, a study finds. Medscape Medical News
Study Backs Longer Compounded Lido Plus Epi Shelf Life
Research supports the safety and efficacy of compounded lidocaine plus epinephrine for up to 24 hours at room temperature and up to 7 days with refrigeration. Medscape Medical News
PET/CT Can Catch Cranial GCA Missed by Doppler Ultrasound
Digital FDG PET/CT can pick up cranial giant cell arteritis that may be missed on ultrasound because of a lack of trunk large-vessel involvement. Medscape Medical News
Ocular Therapeutix’s Eye Drug Superior to Regeneron’s Eylea in Late-stage Trial
Ocular Therapeutix said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron’s approved treatment… Reuters Health Information
Ocular Therapeutix Plunges as Modest Benefit Overshadow Trial Win Over Regeneron’s Eylea
Ocular Therapeutix’s experimental eye drug showed superiority to Regeneron’s Eylea in a key late-stage trial, but its modest advantage and higher rates of certain side… Reuters Health Information
New Rx Option for Neuromyelitis Optica Spectrum Disorder?
Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder. Medscape Medical News